OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors
Norikazu Matsuo, Koichi Azuma, Kenta Murotani, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 15, pp. 1362-1367
Open Access | Times Cited: 17

Showing 17 citing articles:

Weight and Blood‐Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients
Steven Tran, Noah Forrest, Vijeeth Guggilla, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Prevalence of and survival with cachexia among patients with cancer: A systematic review and meta-analysis
Tomoya Takaoka, Akinori Yaegashi, Daiki Watanabe
Advances in Nutrition (2024) Vol. 15, Iss. 9, pp. 100282-100282
Open Access | Times Cited: 3

Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer
Utae Katsushima, Kimitaka Hase, Takuya Fukushima, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 3, pp. 305-311
Closed Access | Times Cited: 2

Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study
Kosei Doshita, Tateaki Naito, Suguru Matsuda, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 25, pp. 1831-1841
Open Access | Times Cited: 2

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
Daiki Murata, Koichi Azuma, Norikazu Matsuo, et al.
Cancer Medicine (2023) Vol. 12, Iss. 19, pp. 19471-19479
Open Access | Times Cited: 6

Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients
Yean Yu, Yan Li, Tianhui Huang, et al.
Aging (2024) Vol. 16, Iss. 6, pp. 5354-5369
Open Access | Times Cited: 1

Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis
Junfang Zhang, Xuan Tang, Wenbo Zhang, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1618-1625
Closed Access | Times Cited: 1

The role of pharmacists in multimodal cancer cachexia care
Hironori Fujii, Yunami Yamada, Hirotoshi Iihara, et al.
Asia-Pacific Journal of Oncology Nursing (2023) Vol. 10, pp. 100280-100280
Open Access | Times Cited: 3

The landscape of immune therapy in vulnerable patients with advanced non-small cell lung cancer: a narrative review
Kenji Morimoto, Tadaaki Yamada, Koichi Takayama
Translational Lung Cancer Research (2023) Vol. 12, Iss. 11, pp. 2310-2321
Open Access | Times Cited: 3

SOP – Inappetenz und Kachexie
Thomas Gelbrich, Bernd Alt‐Epping, Christina Gerlach
best practice onkologie (2024)
Closed Access

Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?
Valentina Bartolomeo, Mandy Jongbloed, Wouter R. P. H. van de Worp, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 230-230
Open Access

Exploring the Relationship Between Anorexia and Therapeutic Efficacy in Advanced Lung Cancer Treatment: A Retrospective Study
Kosei Doshita, Tateaki Naito, Suguru Matsuda, et al.
Research Square (Research Square) (2024)
Open Access

SOP—loss of appetite and cachexia
Thomas Gelbrich, Bernd Alt‐Epping, Christina Gerlach
Deleted Journal (2024) Vol. 30, Iss. 8, pp. 746-754
Closed Access

Page 1

Scroll to top